Inovio and Partner Advance MERS Vaccine
GeneOne Life Science Inc., which partnered with Inovio Pharmaceuticals, Inc. to develop Inovio’s MERS vaccine (GLS-5300), announced the filing of an Investigational New Drug Application for GLS-5300 with the United States Food and Drug Administration. [Inovio Pharmaceuticals, Inc.] Press Release